Back to Clinical Trials Overview

Your search for "Blood Disorders" returned 9 results:


A Phase 2, randomized, multicenter, placebo-controlled, double-blind, parallel-group study to evaluate the efficacy, safety and population PKs of once-daily oral E5501 tablets used up to 7 days in subjects with chronic liver diseases and thrombocytopenia prior to elective surgical or diagnostic procedures
Principal Investigator(s): Chang, Charissa

A Phase II , Single-Center, Open Label study of Oral Panobinostat (LBH589) when administered in combination with Lenalidomide and weekly Dexamethasone in patients with multiple myeloma
Principal Investigator(s): Ajai Chari

Intensified Methotrexate,Nelarabine & Augmented BFM Ther (AALL0434)
Principal Investigator(s): Birte Wistinghausen

A Multi-center, double-blind, randomized study evaluating de novo weekly and once every 2 week darbepoetin alfa dosing for the correction of anemia in pediatric subjects with chronic kidney disease recieving and not receiving dialysis
Principal Investigator(s): Benchimol, Corinne

Clarification of Optimal Anticoagulation through Genetics (COAG)
Principal Investigator(s): Desnick, Robert J.

An Oservational, ex vivo Clinical Trial of Intrinsic Pathway Antagonists in Patients Undergoing Warfarin Therapy
Principal Investigator(s): Moskowitz, Alan

Phase I 01910.Na Infusion w/Leukemia or Myelodyspastic MDS
Principal Investigator(s): Lewis R. Silverman

Anti IL-5 (Mepolizumab) Treatment in Hypereosinophilic
Principal Investigator(s): Busse, Paula J

Hemophagocytic Lymphohistiocystosis Study Group
Principal Investigator(s): Del Toro, Gustavo